Rockefeller Capital Management L.P. Veracyte, Inc. Transaction History

Rockefeller Capital Management L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 06, 2023	SELL	$15.31 - $29.94 $5,220 - $10,209	-341 Reduced 83.58%	67 $1,000
Q3 2022 Nov 02, 2022	SELL	$16.58 - $27.9 $5,487 - $9,234	-331 Reduced 44.79%	408 $6,000
Q2 2022 Aug 12, 2022	BUY	$15.45 - $29.52 $7,894 - $15,084	511 Added 224.12%	739 $14,000
Q1 2022 May 13, 2022	SELL	$21.94 - $42.51 $4,760 - $9,224	-217 Reduced 48.76%	228 $6,000
Q4 2021 Feb 14, 2022	BUY	$36.09 - $53.79 $4,366 - $6,508	121 Added 37.35%	445 $17,000
Q3 2021 Nov 12, 2021	SELL	$35.62 - $52.97 $3,455 - $5,138	-97 Reduced 23.04%	324 $15,000
Q1 2021 May 11, 2021	BUY	$44.47 - $81.38 $2,001 - $3,662	45 Added 11.97%	421 $22,000
Q4 2020 Feb 12, 2021	BUY	$32.49 - $61.88 $9,064 - $17,264	279 Added 287.63%	376 $18,000
Q1 2020 May 12, 2020	BUY	$16.13 - $30.17 $1,564 - $2,926	97 New	97 $2,000

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.